BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8889361)

  • 1. Argatroban: a synthetic thrombin inhibitor of low relative molecular mass.
    Fitzgerald D; Murphy N
    Coron Artery Dis; 1996 Jun; 7(6):455-8. PubMed ID: 8889361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A synopsis of the clinical uses of argatroban.
    Moledina M; Chakir M; Gandhi PJ
    J Thromb Thrombolysis; 2001 Oct; 12(2):141-9. PubMed ID: 11729365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of argatroban, a direct thrombin inhibitor, and its clinical application.
    Matsuo T; Koide M; Kario K
    Semin Thromb Hemost; 1997; 23(6):517-22. PubMed ID: 9469623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of argatroban on thrombus formation during acute coronary occlusion after balloon angioplasty.
    Suzuki S; Sakamoto S; Adachi K; Mizutani K; Koide M; Ohga N; Miki T; Matsuo T
    Thromb Res; 1995 Feb; 77(4):369-73. PubMed ID: 7740527
    [No Abstract]   [Full Text] [Related]  

  • 5. Argatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectives.
    Serebruany MV; Malinin AI; Serebruany VL
    Expert Opin Pharmacother; 2006 Jan; 7(1):81-9. PubMed ID: 16370925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris.
    Gold HK; Torres FW; Garabedian HD; Werner W; Jang IK; Khan A; Hagstrom JN; Yasuda T; Leinbach RC; Newell JB
    J Am Coll Cardiol; 1993 Apr; 21(5):1039-47. PubMed ID: 8459055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor.
    Hursting MJ; Alford KL; Becker JC; Brooks RL; Joffrion JL; Knappenberger GD; Kogan PW; Kogan TP; McKinney AA; Schwarz RP
    Semin Thromb Hemost; 1997; 23(6):503-16. PubMed ID: 9469622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of the synthetic thrombin inhibitor, argatroban (MD-805).
    Matsuo T; Kario K; Kodama K; Okamoto S
    Semin Thromb Hemost; 1992; 18(2):155-60. PubMed ID: 1631564
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibitory effect of argatroban on thrombin-antithrombin III complex after percutaneous transluminal coronary angioplasty.
    Sakamoto S; Hirase T; Suzuki S; Tsukamoto T; Miki T; Yamada T; Matsuo T
    Thromb Haemost; 1995 Aug; 74(2):801-2. PubMed ID: 8585029
    [No Abstract]   [Full Text] [Related]  

  • 10. Argatroban.
    Kathiresan S; Shiomura J; Jang IK
    J Thromb Thrombolysis; 2002 Feb; 13(1):41-7. PubMed ID: 11994559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A specific thrombin inhibitor (argatroban) ameliorated cerebral blood flow in the patients with acute cerebral infarction.
    Maruki Y; Onoda A; Matsuzaki M; Narabayashi Y; Sawada M; Shimazu K
    Keio J Med; 2000 Feb; 49 Suppl 1():A138-40. PubMed ID: 10750365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.
    Imura Y; Stassen JM; Collen D
    J Pharmacol Exp Ther; 1992 Jun; 261(3):895-8. PubMed ID: 1602394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin inhibitors in unstable angina: rebound or continuation of angina after argatroban withdrawal?
    Willerson JT; Casscells W
    J Am Coll Cardiol; 1993 Apr; 21(5):1048-51. PubMed ID: 8459056
    [No Abstract]   [Full Text] [Related]  

  • 14. Small-molecule direct antithrombins: argatroban.
    Fareed J; Jeske WP
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):127-38. PubMed ID: 15171962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local treatment with an antithrombotic drug reduces thrombus size in coronary and peripheral thrombosed arteries.
    Tomaru T; Nakamura F; Aoki N; Sakamoto Y; Omata M; Uchida Y
    Heart Vessels; 1996; 11(3):133-44. PubMed ID: 8897062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
    Lewis BE; Walenga JM; Wallis DE
    Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis.
    Kobayashi S; Tazaki Y
    Semin Thromb Hemost; 1997; 23(6):531-4. PubMed ID: 9469625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Argatroban, a selective thrombin inhibitor, for anticoagulant therapy during and following vascular surgery].
    Fuji H; Kurasako N; Takebayashi T; Tanaka T; Sakano S; Kosogabe Y; Mano M; Nagase H
    Masui; 1996 Oct; 45(10):1289-92. PubMed ID: 8937032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reperfusion, specific thrombin inhibition and reocclusion after thrombolysis.
    Chesebro JH; Fuster V
    J Am Coll Cardiol; 1990 Sep; 16(3):723-5. PubMed ID: 2117621
    [No Abstract]   [Full Text] [Related]  

  • 20. Hereditary heparin cofactor II deficiency and coronary artery disease.
    Matsuo T; Kario K; Sakamoto S; Yamada T; Miki T; Hirase T; Kobayashi H
    Thromb Res; 1992 Mar; 65(4-5):495-505. PubMed ID: 1615493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.